Pricing challenge in US biz, rich valuations may weigh on pharma stocks

The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......

Titan's near-term margin headwinds on watch

There could be near-term margin pressures for lifestyle accessories major Titan Company. Photograph: Courtesy, Titanwatches/X Even as the company maintains its growth outlook over the medium......

Brokerages raise targets on RIL stock post Q4

The bullish outlook stems from Reliance Jio's potential tariff hikes, given the competitive landscape, along with slow but steady improvement in the oil-to-chemical (O2C) vertical Photograph: ANI......

HDFC Bank Q4 performance and future outlook

Amid tepid quarterly growth and withheld guidance, HDFC Bank may emerge as a contrarian choice for investors seeking long-term value Photograph: Shailesh Andrade/Reuters HDFC Bank's January-March......